These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15541962)

  • 1. Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfalls.
    Gion M; Daidone MG
    Eur J Cancer; 2004 Nov; 40(17):2613-22. PubMed ID: 15541962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour-derived predictive biomarkers in oncology.
    Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
    Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers and TNM classification].
    Ohkura H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1981-4. PubMed ID: 9797825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 7. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories.
    Rothman N; Stewart WF; Schulte PA
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):301-11. PubMed ID: 7655323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A; Al-Mohanna M; Linder S
    J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer biomarker problem.
    Sawyers CL
    Nature; 2008 Apr; 452(7187):548-52. PubMed ID: 18385728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
    Draghici S; Chatterjee M; Tainsky MA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.
    Cordero OJ; De Chiara L; Lemos-González Y; Páez de la Cadena M; Rodríguez-Berrocal FJ
    Anticancer Res; 2008; 28(4C):2333-41. PubMed ID: 18751415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarker profiling in cancer studies: a question of standardisation?
    Matharoo-Ball B; Miles AK; Creaser CS; Ball G; Rees R
    Vet Comp Oncol; 2008 Dec; 6(4):224-47. PubMed ID: 19178682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
    Gadducci A; Cosio S; Tana R; Genazzani AR
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.